COMPARISON OF TOTAL ANTIOXIDANT CAPACITY (TAC)'S PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS AND NON-HEMODIALYSIS
Downloads
Background: Total antioxidant capacity (TAC) is one of the biomarkers to determine a person's health condition through antioxidant and oxidant activity or oxidative stress so that it can help in determining the therapy needed. However, currently, TAC levels in patients with chronic kidney disease (CKD) undergoing hemodialysis (HD) and non-hemodialysis (non-HD) are still controversial, so further research is needed. Objective: To analyze the comparison of TAC in HD and non-HD CKD patient. Materials and Methods: This was an analytical cross-sectional study with clinical observation in CKD patient. A total of 71 CKD patients consisting of 28 CKD HD patients and 43 non-HD CKD patients were enrolled in this study. Data about the characteristics of the subjects were taken using the anamnesis method, while data about TAC were taken using the colorimetric method with COBAS C-501 0837-19 series and 0835-13 series to measure TAC levels in the serum of CKD patients. The data that has been obtained were analyzed using independent sample t-tests. Results: TAC levels were significantly higher in CKD patients undergoing HD compared to non-HD CKD patients (p <0.05). There are data on albumin as an antioxidant and MDA as an oxidative stress biomarker that affects TAC levels. Conclusion: TAC levels found to be higher in hemodialysis CKD patient compared to non-hemodialysis CKD patient.
Almansa, I., Barcia, J.M., López-Pedrajas, R., Muriach, M., Miranda., Romero, F.J., 2013. Naltrexone reverses ethanol-induced rat hippocampal and serum oxidative damage. Oxidative Medicine and Cellular Longevity. 2013
Berns, J.S, 2018. Patient education: Hemodialysis (Beyond the Basics). Downloaded 4 May 2018 from https://www.uptodate.com/contents/hemod ialysis-beyond-the-basics/print
Buico, A., Cassino, C., Ravera, M., Betta, P., Osella, D., 2009. Oxidative stress and total antioxidant capacity in human plasma. Redox Report, 14(3): 125–31.
Cohen, G., Hörl, W.H., 2012. Immune dysfunction in uremia. An update. Toxins, 4(11): 962–90.
Coombes, J.S., Fassett, R.G., 2012. Antioxidant therapy in hemodialysis patients: A systematic review. Kidney International, 81(3): 233–46.
Delaney, M.P., Price C.P., Newman D.J., 2006. Kidney disease. In: E. Lamb, ed. Tietz Texstbook of Clinical Biochemistry. 4th ed. Saunder. 1670–1745..
Filiopoulos, V., Hadjiyannakos, D., Takouli, L., Metaxaki, P., Sideris, V., Vlassopoulos, D., 2009. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs, 32(12): 872–82.
Flores-Bellver, M., Bonet-Ponce, L., Barcia, J. et al. 2014. Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol: implications of 4-hydroxy-nonenal. Cell Death Dis, 5: e1328
Goldberg H.J., Scholey J., Fantus I. G., 2000. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes, 49(5): 863–71.
Kidney Health Australia, 2015. Albuminuria. Downloaded 20 October 2018 from https://kidney.org.au/cms_uploads/docs/al buminuria-fact-sheet.pdf
Kuo, K.L., Tarng, D.C., 2010. Oxidative stress in chronic kidney disease. Adaptive Medicine, 2(2), 87–94.
Labriola, L., Jadoul, M., 2017. Dialysis-related amyloidosis: Is it gone or should it be? Seminars in Dialysis. 30(3):193-6.
Ladi-Akinyemi, T.W., Ajayi, I., 2017. Risk factors for chronic kidney disease among patients at Olabisi Onabanjo University Teaching Hospital in Sagamu, Nigeria: a retrospective cohort study. Malawi Med J , 29(2), 166–70.
Liakopoulos, V., Roumeliotis, S., Gorny, X., Dounousi, E., Mertens, P.R., 2017. Oxidative stress in hemodialysis patients: a review of the literature. Oxidative Medicine and Cellular Longevity, 2017.
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., Abete, P., 2018. Oxidative stress, aging, and diseases. Clinical Interventions in Aging, 13: 757–72.
Mayer, B., Zitta, S., Greilberger, J., Holzer, H., Reibnegger, G., Hermetter, A., Oettl, K., 2003. Effect of hemodialysis on the antioxidative properties of serum. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1638(3): 267–72.
Medscape, 2018. Do I need a microalbumin urine test? Downloaded 22 October 2018 from https://www.webmd.com/diabetes/urine- test-microalbumin#2
Montazerifar, F., Karajibani, M., Sanadgol, H., Hashemi, M., 2012. Effect of peritoneal dialysis on antioxidant defense system and oxidative stress. Hong Kong Journal of Nephrology, 14(2): 33–7.
NIDDK, 2018. Albuminuria: Albumin in the urine. Downloaded 22 October 2018 from https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests- diagnosis/albuminuria-albumin-urine
Nsonwu-Anyanwu, A., Offor, S., John, I., 2018. Cigarette smoke and oxidative stress indices in male active smokers. Reactive Oxygen Species, 5(15): 199-208.
Putri, A.Y., Thaha, M., 2014. Role of oxidative stress on chronic kidney disease progression,.Acta Medica Indonesiana, 46(3): 244–52.
Roumeliotis, S., Roumeliotis, A., Dounousi, E., Eleftheriadis, T., Liakopoulos, V. 2019. Dietary antioxidant supplements and uric acid in Chronic Kidney Disease: A Review. Nutrients, 11(8): 1911.
Sheen, Y.J., Sheu, W.H.H., 2011. Metabolic syndrome and renal injury. Cardiology Research and Practice, 2011: 1–13.
Sundaram, M.S., Nagarajan, S., Jagdeeshwaran, A., Devi, Manjula A.J., 2014. Chronic kidney disease ” effect of oxidative stress. Chinese Journal of Biology, 2014: 1–6.
Tajbakhsh, R., Qorbani, M., Mehrpour, G., Rahimzadeh, M., Azimzadeh., M.M., Mirmiranpour, H., 2017. Effect of hemodialysis on oxidants and antioxidant factors in chronic renal failure. Saudi Journal of Kidney Diseases and Transplantation, 28(3): 507-16.
Tangvarasittichai, S., 2015. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World Journal of Diabetes, 6(3): 456.
Thaha, M., Empitu, M.A., Kadariswantiningsih, I.N., Santoso, D., Tomino, Y., 2017. [Untitled work]. Unpublished raw data.
van der Vaart, H., Postma, D.S., Timens, W., Hylkema, M.N., Willemse, B.W.M., Boezen, H.M., Vonk, J.M., de Reus, D.M., Kauffman, H.F., ten H., Nick, H.T., 2005. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respiratory Research, 6(1):22.
1. The journal allows the author(s) to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International License (CC-BY).
